SLDB vs. RXRX
Compare and contrast key facts about Solid Biosciences Inc. (SLDB) and Recursion Pharmaceuticals, Inc. (RXRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SLDB or RXRX.
Correlation
The correlation between SLDB and RXRX is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SLDB vs. RXRX - Performance Comparison
Key characteristics
SLDB:
-0.57
RXRX:
0.09
SLDB:
-0.55
RXRX:
0.80
SLDB:
0.94
RXRX:
1.09
SLDB:
-0.49
RXRX:
0.09
SLDB:
-0.94
RXRX:
0.15
SLDB:
51.60%
RXRX:
49.42%
SLDB:
83.38%
RXRX:
87.62%
SLDB:
-99.76%
RXRX:
-88.97%
SLDB:
-99.48%
RXRX:
-74.52%
Fundamentals
SLDB:
$161.02M
RXRX:
$4.04B
SLDB:
-$3.11
RXRX:
-$1.91
SLDB:
$0.00
RXRX:
$54.29M
SLDB:
-$1.56M
RXRX:
$14.55M
SLDB:
-$82.81M
RXRX:
-$262.33M
Returns By Period
In the year-to-date period, SLDB achieves a 0.75% return, which is significantly lower than RXRX's 55.77% return.
SLDB
0.75%
28.34%
-54.57%
-59.00%
-39.03%
N/A
RXRX
55.77%
64.02%
56.23%
-15.29%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SLDB vs. RXRX — Risk-Adjusted Performance Rank
SLDB
RXRX
SLDB vs. RXRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Solid Biosciences Inc. (SLDB) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SLDB vs. RXRX - Dividend Comparison
Neither SLDB nor RXRX has paid dividends to shareholders.
Drawdowns
SLDB vs. RXRX - Drawdown Comparison
The maximum SLDB drawdown since its inception was -99.76%, which is greater than RXRX's maximum drawdown of -88.97%. Use the drawdown chart below to compare losses from any high point for SLDB and RXRX. For additional features, visit the drawdowns tool.
Volatility
SLDB vs. RXRX - Volatility Comparison
The current volatility for Solid Biosciences Inc. (SLDB) is 27.18%, while Recursion Pharmaceuticals, Inc. (RXRX) has a volatility of 29.24%. This indicates that SLDB experiences smaller price fluctuations and is considered to be less risky than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SLDB vs. RXRX - Financials Comparison
This section allows you to compare key financial metrics between Solid Biosciences Inc. and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities